Test of cell-based treatment for ALS and MS
Part of Brain & nervous system, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a therapy made from human amniotic cells to help reduce brain inflammation and damage. It may be an option for people with ALS or multiple sclerosis who meet the age and health requirements, as well as healthy volunteers to serve as a comparison group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ALS, multiple sclerosis, or are a healthy spouse of a patient.
- If you have ALS, you must be between 50 and 60 years old.
- If you have multiple sclerosis, you must be between 20 and 50 years old.
- If you have MS, you must not be in an acute flare-up or have used certain MS drugs recently.
- You must be willing to participate and give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This trial studies the “innate immune system” (your body’s first-line immune response) in people with ALS and in comparison groups. It may help researchers understand what drives ALS and how immune changes could relate to symptoms.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at people with amyotrophic lateral sclerosis (ALS), people who might have ALS, and also people related to someone with ALS. It may help researchers better understand ALS and related “motor neuron” conditions, and it involves participation that may include blood tests.
This study tests a new treatment called Q-Cells®, which are special cells injected into the spinal cord to see if they can help slow ALS. It is for people with ALS who have a caregiver and are healthy enough to undergo the procedure.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.